Vol. 8 No. 1 (2001)

Published: 2001-08-01

Editorial

A civic duty

John M Sime
- PDF

Commentary

Lessons learned

Jeremy Curnock Cook
- PDF

Article

Becoming a premier partner: Measuring, managing and changing partnering capabilities at Eli Lilly and Company

David Futrell, Marlene Slugay, Carol H Stephens
- PDF
Solid organ xenotransplantation: Progress, promise and regulatory issues

Julia L Greenstein, Henk-Jan Schuurman
- PDF
The human stem cells debate: A UK perspective

Tor Lezemore, Susan Bull
- PDF
The European Clinical Trials Directive: What does this mean for the biopharmaceutical industry?

Simon Bryson
- PDF
Biomanufacturing capacity: Current and future requirements

Andrew Sinclair
- PDF
Strategies for improving communication between scientists and the public

Belinda R Clarke
- PDF
Key indicators of the German equipment and supplies industry

Stefan Woerner, Thomas Reiss
- PDF
Cell therapy: European legal and regulatory implications

Scott Parker
- PDF

Legal and Regulatory Updates

Legal and Regulatory Update

John Wilkinson
- PDF
EU Financial accounts reports

David Citron
- PDF
US Financial accounts reports

Glenn Crocker
- PDF